Is FDA up or down today?
FDA is up 0.65% today, last at 38.21. This stock moved +0.65% versus the prior close.
FDA · FDA
FDA (FDA) is trading at 38.21, up 0.65% on the session. FDA sits at the 50% mark of its 52-week range, carries a 14-day RSI of 59, and trades above its 50-day average. Over the past month it is up 3.88%.
Leading the coverage: “Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test - The Motley Fool” (Google News Company, 4d ago). FDA is -1.27% since story.
FDA trades on a trailing P/E of 9.7 and is running 4.82% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
FDA is up 0.65% today, last at 38.21. This stock moved +0.65% versus the prior close.
Leading the coverage: “Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test - The Motley Fool” (Google News Company, 4d ago). FDA is -1.27% since story. Dominant story: Abbott Laboratories stock gains after FDA approval and strong guidance - AD HOC NEWS (1 source, bullish) RSI is 59 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (181 days) · Drag or scroll left for earlier dates
Abbott Laboratories stock gains after FDA approval and strong guidance - AD HOC NEWS
Philip Morris International (PM) Gets FDA Clearance And Lifts Guidance As Valuation Stays In Focus - simplywall.st
Citizens reiterates Intellia stock rating on FDA priority review By Investing.com - Investing.com Canada
Health Check: ‘Frustrated’ Echo IQ ponders next move after shock FDA setback - Stockhead
CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing - stocktwits.com